People · Operator
Named in public records as an officer, director or promoter · active 2024–2024 · Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Notch Therapeutics, Inc. | — | Pharma | Series B | $15.5M | $113.9M | 2024 |
Ulrik R. Nielsen at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Ulrik R. Nielsen on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Stephen R. Biggar | 1 | 3 |
| David Main | 1 | 2 |
| Bernard R. Lam | 1 | 1 |
| Kamran R. Alam | 1 | 1 |
| Heather R. Lee | 1 | 1 |
| Emily R. Titus | 1 | 1 |
| Janet R. Rossant | 1 | 1 |
| Chris R. Bond | 1 | 1 |
| Caroline R. Stout | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.